BIO-B
Bio-Rad Laboratories, Inc.
Medical Devices · Healthcare · United States
379.50
close · 2026-10-27
value
43
cheaper than peers43
quality
66
stronger fundamentals66
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.41× | 74 |
| price to sales | 3.77× | 35 |
| EV to EBITDA | 19.87× | 34 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 11.2% | 80 |
| return on equity | 3.1% | 70 |
| debt to equity | 19.1% | 67 |
| revenue growth | -0.1% | 21 |
4 of 4 measures available
Facts
| market cap | $10B |
| free cash flow | $283.2M |
| employees | 7,450 |
| first trade | 1999-09-21 |
| next earnings | not reported |
| fundamentals updated | 2026-08-20 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 27.85 | -65.36 | -21.82 | -121.79 |
| free cash flow | $374.6M | $266.2M | $218.2M | $80.1M |
| net income | $759.9M | -$1.84B | -$637.3M | -$3.63B |
| revenue | $2.58B | $2.57B | $2.67B | $2.80B |
| unusual items | $729.2M | -$2.65B | -$1.24B | -$5.20B |